Walgreens Boots Alliance Inc (WBA) Shares Bought by Meiji Yasuda Life Insurance Co

Meiji Yasuda Life Insurance Co lifted its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 1.8% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 34,781 shares of the pharmacy operator’s stock after acquiring an additional 600 shares during the period. Meiji Yasuda Life Insurance Co’s holdings in Walgreens Boots Alliance were worth $2,724,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of the company. State Street Corp raised its position in shares of Walgreens Boots Alliance by 1.8% during the 1st quarter. State Street Corp now owns 37,612,843 shares of the pharmacy operator’s stock worth $3,123,757,000 after acquiring an additional 677,743 shares in the last quarter. Wellington Management Group LLP raised its position in shares of Walgreens Boots Alliance by 5.9% during the 1st quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator’s stock worth $2,727,932,000 after acquiring an additional 1,824,300 shares in the last quarter. Nordea Investment Management AB raised its position in shares of Walgreens Boots Alliance by 26.5% during the 1st quarter. Nordea Investment Management AB now owns 9,154,328 shares of the pharmacy operator’s stock worth $760,267,000 after acquiring an additional 1,917,082 shares in the last quarter. TIAA CREF Investment Management LLC raised its position in shares of Walgreens Boots Alliance by 22.4% during the 1st quarter. TIAA CREF Investment Management LLC now owns 5,269,500 shares of the pharmacy operator’s stock worth $437,632,000 after acquiring an additional 962,959 shares in the last quarter. Finally, Legal & General Group Plc raised its position in shares of Walgreens Boots Alliance by 5.2% during the 2nd quarter. Legal & General Group Plc now owns 4,550,856 shares of the pharmacy operator’s stock worth $356,368,000 after acquiring an additional 223,186 shares in the last quarter. 60.24% of the stock is currently owned by institutional investors and hedge funds.

In other news, Director John Anthony Lederer acquired 20,000 shares of the business’s stock in a transaction that occurred on Thursday, October 26th. The stock was acquired at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the completion of the acquisition, the director now owns 50,000 shares in the company, valued at $3,350,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 13.50% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: This story was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this story on another publication, it was stolen and republished in violation of United States and international trademark & copyright laws. The original version of this story can be accessed at https://sportsperspectives.com/2017/11/02/walgreens-boots-alliance-inc-wba-shares-bought-by-meiji-yasuda-life-insurance-co.html.

A number of research analysts recently issued reports on WBA shares. Pivotal Research dropped their price target on Walgreens Boots Alliance from $85.00 to $73.00 and set a “hold” rating on the stock in a research note on Tuesday, October 24th. Loop Capital started coverage on Walgreens Boots Alliance in a research note on Thursday, August 24th. They set a “buy” rating and a $95.00 price target on the stock. Needham & Company LLC restated a “buy” rating and set a $94.00 price target on shares of Walgreens Boots Alliance in a research note on Thursday, October 12th. BidaskClub downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, September 12th. Finally, Royal Bank Of Canada restated a “buy” rating and set a $88.00 price target on shares of Walgreens Boots Alliance in a research note on Wednesday, October 25th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have issued a buy rating to the company’s stock. Walgreens Boots Alliance currently has an average rating of “Buy” and a consensus price target of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.21 by $0.10. The company had revenue of $30.15 billion during the quarter, compared to analyst estimates of $29.93 billion. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The company’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.07 earnings per share.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, November 10th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.41%. Walgreens Boots Alliance’s payout ratio is currently 42.33%.

Walgreens Boots Alliance declared that its board has approved a stock buyback program on Wednesday, October 25th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the pharmacy operator to repurchase shares of its stock through open market purchases. Shares buyback programs are typically a sign that the company’s board of directors believes its stock is undervalued.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply